What if… we could unlock the full power of precision medicine?
Transforming Treatments Means Transforming Lives
We are pioneers of silicon-based Bio-Courier® technology, an advanced and highly tailored approach that advances drug delivery into the age of precision medicine. Built upon a decade of research and patented technological innovation, our platform is changing the way therapeutic molecules target disease helping to make tomorrow’s medicines a reality.
SiSaf is a commercial stage biopharmaceutical company. Our pipeline of transformative Gene Therapies, accelerated New Therapeutic Entities and advanced Personal Care development candidates create multiple blockbuster opportunities.
Team
Led by an authority in the delivery of nucleic acid and silicon innovation, Dr Suzanne Saffie-Siebert, our expert team is focused on driving clinical and commercial success.
Technology
SiSaf’s Bio-Courier platform leverages the unique properties of the worlds 1st bioabsorbable silicon (14Si) to overcome the limitations of current drug technologies.
Why Sisaf?
We’re creating multiple block-buster product opportunities with the safe and efficient non-viral delivery of gene therapy and a faster, lower risk approach to drug development.